What D03 covers · when clinicians use it
ICD-10 code D03 identifies Melanoma in situ in the U.S. ICD-10-CM clinical and billing record set. It sits within the Neoplasms chapter (C00–D49), the section that groups related diagnoses so providers, payers, and public-health agencies report them consistently. Clinicians and medical coders apply D03 when an encounter's findings match the Melanoma in situ description, attaching it to the patient record so downstream insurance claims, payer audits, quality reporting, and epidemiological surveillance all reference the same standardized diagnosis. The ICD-10-CM is maintained by the Centers for Medicare & Medicaid Services and the CDC's National Center for Health Statistics, with an updated official code set released each U.S. fiscal year — always verify D03 against the current CMS/CDC release and your payer's documentation guidance before final use. This page summarizes documentation context for D03 and is a coding reference, not clinical, diagnostic, or billing advice.
D03 refers to Melanoma in situ, which describes early-stage, localized cancerous changes that have not yet invaded surrounding tissues. Carcinoma in situ is considered a precancerous condition or the earliest form of cancer and is often discovered during routine screening or diagnostic evaluations.
Symptoms
- Often asymptomatic – Detected through screening (e.g., Pap smear, mammogram)
- Visible lesion – Skin changes in melanoma in situ
- Abnormal test results – Colposcopy, endoscopy, or imaging
- Minor bleeding or discharge – Especially in cervical or genital carcinoma in situ
- Unusual moles or skin patches – In cases of melanoma or skin involvement
- Localized swelling – Rare, may occur near superficial lesions
- Persistent sore – In oral or respiratory tract involvement
Diagnosis
Diagnosis of Melanoma in situ involves biopsy and histological evaluation confirming abnormal cell growth confined to the epithelial layer. It may follow a screening test (e.g., Pap smear, mammogram, dermoscopy) or imaging. Early detection allows for curative treatment before invasion occurs.
ICD10 Code Usage
ICD10 code D03 is used to document pre-invasive cancer or carcinoma in situ in medical records. It ensures correct classification for insurance, patient follow-up, cancer prevention strategies, and clinical research data.
Related Codes
- D00 – Carcinoma in situ of oral cavity, esophagus and stomach
- D01 – Carcinoma in situ of other and unspecified digestive organs
- D02 – Carcinoma in situ of middle ear and respiratory system
- D04 – Carcinoma in situ of skin
- D05 – Carcinoma in situ of breast
- D06 – Carcinoma in situ of cervix uteri
- D07 – Carcinoma in situ of other and unspecified genital organs
- D09 – Carcinoma in situ of other and unspecified sites
FAQs
Q1: What is ICD10 code D03?
A: This code identifies Melanoma in situ, where cancerous cells are present but have not yet spread or invaded other tissues.
Q2: Is carcinoma in situ cancer?
A: It is considered stage 0 cancer or a precancerous condition with no invasion yet.
Q3: How is it treated?
A: Treatments include surgical excision, laser therapy, or local topical medications depending on the site and type.
Q4: Can it turn into invasive cancer?
A: Yes, if untreated, it has the potential to become invasive, depending on type and location.
Q5: Is it included in cancer registries?
A: Yes, carcinoma in situ is recorded for surveillance and monitoring in early cancer detection programs.
Conclusion
ICD10 code D03 is crucial for documenting and managing Melanoma in situ. It supports early diagnosis, effective treatment, and prevents progression to invasive cancer. Proper coding also aids in epidemiological tracking and cancer prevention efforts across healthcare systems.